Evidence map›Paper›PMID 29700213›Full record

ArticleBioscience reports2019

MiR-382 functions as tumor suppressor and chemosensitizer in colorectal cancer.

Hui Yao, Dong Xia, Zong-Lin Li, Lei Ren, Ming-Ming Wang, Wang-Sheng Chen, Zheng-Chuan Hu, Guo-Ping Yi, Liang Xu

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Reduced circulating exosomal miR-382 predicts unfavorable outcome in non-small cell lung cancer.International journal of clinical and experimental pathology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Hui YaoDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Dong XiaDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Zong-Lin LiDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Lei RenDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Ming-Ming WangDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Wang-Sheng ChenDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Zheng-Chuan HuDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Guo-Ping YiDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China.
Liang XuDepartment of Gastrointestinal Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province 646000, China xl08289307@163.com.
Affiliated Hospital of Southwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence suggests that microRNAs (miRNAs) play a critical role in tumorigenesis. Decreased expression of miR-382 has been observed in various types of cancers. However, the biological function of miR-382 in colorectal cancer (CRC) is still largely unknown. Here, we found that miR-382 was down-regulated in human colorectal cancer tissues and cell lines associated with it. MiR-382 inhibited colorectal cancer cell proliferation, migration, invasion, and enhance chemosensitivity. Furthermore, we identified Krüppel-like factor 12 (KLF12) and homeodomain-interacting protein kinase 3 (HIPK3) as the target of miR-382, and miR-382 rescued the promotion effect of KFL12 on migration and enhanced chemosensitivity in colorectal cancer cell lines. Collectively, these findings revealed that miR-382 inhibits migration and enhances chemosensitivity by targeting KLF12 and HIPK3 in colorectal cancer. These findings might serve as a tumor suppressor in CRC.

Indexed as

Cell Line, TumorCell MovementCell ProliferationColorectal NeoplasmsDown-RegulationGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHCT116 CellsHumansKruppel-Like Transcription FactorsMicroRNAsKruppel-Like Transcription FactorsMicroRNAsMIRN382 microRNA, humanCDDP resistancecolorectal cancerHIPK3KLF12 signalingmiR-382

Identifiers

PMID29700213
PMCPMC6689104
OpenAlexW2802205708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.